(Q34522246)

2 August 2017

title

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment (English)

1 reference

2 August 2017

0 references

1 reference

F Horak

1

1 reference

2 August 2017

S Jaeger

2

1 reference

2 August 2017

M Worm

3

1 reference

2 August 2017

M Melac

4

1 reference

2 August 2017

A Didier

5

1 reference

2 August 2017

publication date

23 December 2008

1 reference

Clinical & Experimental Allergy

2 August 2017

published in

1 reference

2 August 2017

volume

39

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

394-400

1 reference

Specific immunotherapy for common grass pollen allergies: pertinence of a five grass pollen vaccine

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Allergenic pollen and pollen allergy in Europe

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Sublingual immunotherapy in the treatment of adult allergic rhinitis patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Allergenic pollen records (15 years) and sensitization in patients with respiratory allergy in Thessaloniki, Greece.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234008

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis

27 October 2018

1 reference

12 December 2020

Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I

1 reference

12 December 2020

Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study

1 reference

12 December 2020

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

1 reference

12 December 2020

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

1 reference

12 December 2020

10.1111/J.1365-2222.2008.03153.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference